CDC faces dilemma over recommending new covid booster for all

A small percentage of Americans got the most recent covid-19 booster shot, and even fewer probably realize the federal government is preparing to recommend yet another shot as early as Tuesday.

Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent

March 26, 2024

DocMorris grows in the prescription business and invests incrementally in new Rx customers – Biotech Investments

DocMorris AG / Key word(s): Half Year Results 20-Aug-2024 / 06:58 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

August 21, 2024

After patient death, FDA slaps clinical hold on early-stage AML trial studying 2seventy bio asset

A Seattle Children’s Hospital-led trial studying 2seventy bio’s CD33-targeted CAR-T cell therapy, SC-DARIC33, in acute myeloid leukemia has been put on clinical hold by the

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.